𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Visceral leishmaniasis among liver transplant recipients: An overview

✍ Scribed by Isabel Campos-Varela; Oscar Len; Lluís Castells; Natalia Tallada; Esteban Ribera; Cristina Dopazo; Víctor Vargas; Joan Gavaldà; Ramón Charco


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
178 KB
Volume
14
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis


There has been an increase in the incidence of visceral leishmaniasis (VL), especially among hemopoietic and renal transplant recipients. [1][2][3] Remarkably, very few cases have been described among liver transplant recipients. We report a case of VL in a liver transplant recipient and analyze the other 9 cases published in the literature. 3-


📜 SIMILAR VOLUMES


Appendicitis among liver transplant reci
✍ Peter L. Abt; Ibrahim Abdullah; Kathleen Korenda; Adam Frank; Heather Peterman; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Appendicitis among liver transplant recipients has not been described in the current literature. We report 8 recipients who experienced appendicitis three weeks to 181 months after liver transplantation (LT). Initial presenting findings differed from the nonimmunosuppressed population in that a majo

Probabilities of relapse and abstinence
✍ Thomas P. Beresford 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Andrea DiMartini and her colleagues have provided prospectively gathered data on the course of alcohol use among liver transplant recipients during the first 5 years of postgraft living. Having worked with the difficult issue of alcohol use disorders and liver transplantation for a number of years n

Survival among pediatric liver transplan
✍ Peter L. Abt; Rachel Rapaport-Kelz; Niraj M. Desai; Adam Frank; Seema Sonnad; El 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Segmental liver transplantation with living donor (LD), reduced cadaveric (Reduced), and split cadaveric (Split) allografts has expanded the availability of size-appropriate organs for pediatric recipients. The relevance of recipient age to the selection of graft type has not been fully explored, bu

Who among cytomegalovirus-seropositive l
✍ Nina Singh; Cheryl Wannstedt; Lois Keyes; Marilyn M. Wagener; Thomas V. Cacciare 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

A vast majority of the transplant recipients are cytomegalovirus (CMV)-seropositive (R+). We sought to assess variables predictive of CMV infection, specifically in R+ liver transplant recipients. Study patients comprised 182 consecutive liver transplant recipients who survived at least 14 days afte

An outbreak of vancomycin-resistant Ente
✍ Dominguez, E A ;Davis, J C ;Langnas, A N ;Winfield, B ;Cavalieri, S J ;Rupp, M E 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 161 KB

Vancomycin-resistant Enterococcus faecium (VREF) has become a significant nosocomial pathogen for immunosuppressed patients. During a 5-month period in 1993, 8 cases of invasive infection with VREF (7 with bacteremia) were identified in liver transplant recipients, half of whom were adults. Epidemio

Incidence and diagnosis of active toxopl
✍ Ayşe Caner; Mert Döşkaya; Zeki Karasu; Aysu Değirmenci; Edward Guy; Murat Kılıç; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 1 views

Toxoplasmosis is a serious and potentially life-threatening disease in liver transplant recipients while they are immunosuppressed. We report the clinical and laboratory findings related to active toxoplasma infection associated with 40 immunosuppressed liver transplant procedures that took place ov